Clearside Biomedical, Inc. (CLSD) Suprachoroidal Space Drug Delivery (Transcript)

2d ago, source: Seeking Alpha

Greetings, and welcome to the Clearside Biomedical KOL Webinar. As a reminder, this event is being recorded. I would now like to introduce your host, Jenny Kobin, Clearside Investor Relations. Please ...

Buy Rating Affirmed: Clearside Biomedical’s Innovative Drug Delivery and Promising Clinical Trials

2d ago, source:

Serge Belanger, an analyst from Needham, maintained the Buy rating on Clearside Biomedical (CLSD – Research Report). The associated price ...

Clearside Biomedical, Inc. (CLSD)

7d ago, source: Yahoo Finance

ALPHARETTA, Ga., July 11, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through ...

Clearside Biomedical, Inc. (CLM.MU)

16d ago, source: Yahoo Finance

ALPHARETTA, Ga., July 11, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through ...

Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board

15d ago, source:

We are privileged to welcome Dr. Yiu to our SAB, given his leadership in the research and adoption of new delivery approaches ...

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

29d ago, source: KELOLAND News

ALPHARETTA, Ga., June 27, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through ...

Clearside Biomedical Inc CLM

29d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Clearside Biomedical Inc CLSD

7d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

29d ago, source: Stockhouse

ALPHARETTA, Ga., June 27, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...

Clearside Biomedical Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...